Article Details

FDA Approves CARVYKTI® and ABECMA for Early Treatment of Adult Patients with ...

Retrieved on: 2024-04-08 20:46:43

Tags for this article:

Click the tags to see associated articles and topics

FDA Approves CARVYKTI® and ABECMA for Early Treatment of Adult Patients with .... View article details on hiswai:

Excerpt

It is the largest cohort of multiple myeloma patients treated with this innovative cell therapy and has produced the first multi-center data for ...

Article found on: www.moffitt.org

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo